Feed MET
ME

MetLife

MET · NYSE

$97.15 +0.38% (+$0.37)
1M -0.53%
Market Cap $62.3B
P/E Ratio 17.17x
Div. Yield 2.40%
ROE 12.95%

Bulios Fair Price

$138.04

42.1% upside

Current Price

$97.15

Undervalued Fair Value Overvalued

According to Bulios Fair Price, MET is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
7/9
Valuation
61 /100
Fair
P/B 2.28x
P/E 17.17x
P/S 0.79x
Growth
18 /100
Declining
Book val. growth 1.68%
EPS growth 8.67%
Rev. growth 4.29%
Profitability
14 /100
Weak
Op. margin 6.19%
Net margin 4.61%
FCF margin N/A
Quality
65 /100
Average
Asset turnover 0.11x
ROE 12.95%
ROA 0.48%
Debt
100 /100
Low
Current ratio 453.01x
Net debt/EBITDA N/A
Debt/Equity N/A
Stability
68 /100
Stable
EPS volatility 159.99%
Beta 0.76x
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about MET
Online

About the company

MetLife, Inc. (MET) is an American multinational company providing life insurance, pension planning, and asset management services. With a global presence and a long history, MetLife is one of the leading providers of financial services. The company focuses on providing comprehensive financial solutions and ensuring financial stability for its clients. Shares of MetLife, Inc. (MET) could be suitable for investors looking to invest in the financial services industry with international reach and an emphasis on life insurance and pension planning.

Sector

Financial Services

Industry

Insurance - Life

CEO

Michel Abbas Khalaf

Employees

46,000

Headquarters

New York City

Upcoming events

04 NOV

Earnings

Upcoming earnings report

52d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.